Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 5:7:575483.
doi: 10.3389/fmolb.2020.575483. eCollection 2020.

Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients

Affiliations

Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients

Xingxing Tang et al. Front Mol Biosci. .

Abstract

We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The values of Neutrophil to Lymphocyte Ratio (NLR), derived Neutrophil to Lymphocyte Ratio (dNLR), Platelet to Lymphocyte Ratio (PLR), Lymphocyte to Monocyte Ratio (LMR), Systemic Immune-inflammation Index (SII), and Prognostic Nutritional Index (PNI) were calculated by blood routine test results before operation. After obtaining the postoperative pathology of the patients, the Area Under Curve (AUC) of Receiver Operating Characteristic (ROC) curves was calculated to evaluate the diagnostic value of these IFs in pathology and their corresponding cut-off values. A total of 641 bladder cancer patients were enrolled. The median values of NLR, dNLR, PLR, LMR, SII, and PNI were 6.33, 4.09, 156.47, 2.66, 1114.29, and 51.45, respectively. Grouped patients according to the pathological grade, the NLR, dNLR, PLR, and SII of the high-grade group were significantly higher than those of the low-grade group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while the LMR and PNI were significantly lower than those of the low-grade group (P = 0.003 and P < 0.001). Divided patients into non-muscle invasion group (Tis + Ta + T1) and muscle invasion group (T2 + T3 + T4), in which NLR, dNLR, PLR, and SII in the muscle invasion group were significantly higher than those in the non-muscle invasion group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while LMR and PNI were significantly lower than those in the low-grade group (P = 0.012 and P < 0.001). ROC curves analyses showed that NLR, dNLR, PLR, LMR, SII, and PNI had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively) and muscle invasion (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively). The results suggest the higher NLR, dNLR, PLR, SII, and lower LMR and PNI are associated with higher risk of high-grade and muscle invasive disease. However, this conclusion needs to be further clarified in the future.

Keywords: bladder cancer; derived neutrophil to lymphocyte ratio; inflammatory factors; lymphocyte to monocyte ratio; neutrophil to lymphocyte ratio; platelet to lymphocyte ratio; prognostic nutritional index; systemic immune-inflammation index.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The Receiver Operating Characteristic curves and Area Under Curve of NLR, dNLR, PLR, LMR, SII, and PNI for pathological grade. All these inflammatory factors had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001 and P < 0.001 respectively), and the optimal cut-off values were 4.24, 4.23, 190.44, 2.11, 1337.80, and 51.70, respectively.
FIGURE 2
FIGURE 2
The Receiver Operating Characteristic curves and Area Under Curve of NLR, dNLR, PLR, LMR, SII, and PNI for muscle invasion. All these inflammatory factors had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001 respectively), and the optimal cut-off values were 6.85, 4.23, 248.86, 2.01, 1723.14, and 50.90, respectively.

Similar articles

Cited by

References

    1. Cantiello F., Russo G. I., Vartolomei M. D., Farhan A. R. A., Terracciano D., Musi G., et al. (2018). Systemic inflammatory markers and oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer. Eur. Urol. Oncol. 1 403–410. 10.1016/j.euo.2018.06.006 - DOI - PubMed
    1. Edge S. B., Compton C. C. (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17 1471–1474. 10.1245/s10434-010-0985-4 - DOI - PubMed
    1. Galdiero M. R., Bonavita E., Barajon I., Garlanda C., Mantovani A., Jaillon S. (2013). Tumor associated macrophages and neutrophils in cancer. Immunobiology 218 1402–1410. 10.1016/j.imbio.2013.06.003 - DOI - PubMed
    1. Giannopoulos A., Manousakas T., Gounari A., Constantinides C., Choremi-Papadopoulou H., Dimopoulos C. (2001). Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. J. Urol. 166 470–475. 10.1097/00005392-200108000-00015 - DOI - PubMed
    1. Ginzberg H. H., Vera C., Qin D., Andre C., Mcculloch C. A. G., Shannon P. T., et al. (2001). Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am. J. Physiol. Gastrointest. Liver Physiol. 281 G705–G717. 10.1152/ajpgi.2001.281.3.G705 - DOI - PubMed

LinkOut - more resources